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duration without affecting the energetics of
isolated ventricular trabeculae
June-Chiew Han1*, Kenneth Tran1, Poul MF Nielsen1,2, Andrew J Taberner1,2 and Denis S Loiselle1,3Abstract
Background: Diabetes induces numerous electrical, ionic and biochemical defects in the heart. A general feature
of diabetic myocardium is its low rate of activity, commonly characterised by prolonged twitch duration. This
diabetes-induced mechanical change, however, seems to have no effect on contractile performance (i.e., force
production) at the tissue level. Hence, we hypothesise that diabetes has no effect on either myocardial work output
or heat production and, consequently, the dependence of myocardial efficiency on afterload of diabetic tissue is
the same as that of healthy tissue.
Methods: We used isolated left ventricular trabeculae (streptozotocin-induced diabetes versus control) as our
experimental tissue preparations. We measured a number of indices of mechanical (stress production, twitch
duration, extent of shortening, shortening velocity, shortening power, stiffness, and work output) and energetic
(heat production, change of enthalpy, and efficiency) performance. We calculated efficiency as the ratio of
work output to change of enthalpy (the sum of work and heat).
Results: Consistent with literature results, we showed that peak twitch stress of diabetic tissue was normal
despite suffering prolonged duration. We report, for the first time, the effect of diabetes on mechanoenergetic
performance. We found that the indices of performance listed above were unaffected by diabetes. Hence, since
neither work output nor change of enthalpy was affected, the efficiency-afterload relation of diabetic tissue was
unaffected, as hypothesised.
Conclusions: Diabetes prolongs twitch duration without having an effect on work output or heat production,
and hence efficiency, of isolated ventricular trabeculae. Collectively, our results, arising from isolated trabeculae,
reconcile the discrepancy between the mechanical performance of the whole heart and its tissues.
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A plethora of electrical, ionic and biochemical pheno-
types characterises the myocardium of the STZ-induced
diabetic rat. Prolongation of action potential duration
[1-6] reflects reduction of steady-state [7,8] and transient
outward K+ currents [4,5,7-10], including the delayed
rectifier [1], all of which changes are attributable to down-
regulation of K+ channel gene expression [10]. These
changes result in slowing the rate of diastolic depolarization* Correspondence: j.han@auckland.ac.nz
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unless otherwise stated.[1] and, in consequence, spontaneous rate [1]. These
sarcolemmal alterations anticipate comparable changes
of sarcoplasmic reticular behaviour: prolongation of
the Ca2+ transient [6,11-13], and subsequent decrease
of L-type Ca2+ current [1,7]. Contiguous with these
electrical and ionic changes are reductions in activity
of their associated membrane-bound ATPases: the sar-
colemmal Na+-K+-ATPase [14-16] and the sarcoplasmic
reticular Ca2+-ATPase [17-22]. Comparable slowing of
down-stream mechanical events reflects diminution of the
myofibrillar-ATPase [23-28], with a shift of myosin
heavy chain (MHC) isoenzyme pattern towards the (slow)
β-isoform [20,24,26,29,30].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sponses outlined above comprises the ‘diabetic signature’
and is compatible with the well-known diabetes-induced
prolongation of the twitch, consistently shown at all levels
of the streptozotocin (STZ)-induced diabetic myocardium:
hearts [31-33], papillary muscles [2,3,28,30,34-37], ventricu-
lar trabeculae [6,12], and single myocytes [13,31,38,39].
However, an inconsistency exists between the data arising
from the diabetic heart and that arising from its isolated
tissues. The peak left-ventricular (LV) systolic pressure de-
velopment is reduced in diabetes [27,40-45], but both the
stress (force per cross-sectional area) produced by isolated
papillary muscles [2,3,28,30,34-37], and the peak shorten-
ing of single myocytes [13,46-49], remain unaffected.
We have recently demonstrated [50] that the STZ-
diabetic whole heart in vitro fails to generate as high a
pressure as healthy hearts when confronted by high
afterloads (Figure 1A). That is, diabetes limits the ability
of the heart to pump at high afterloads, which conse-
quently results in a left-shift of the myocardial efficiency-
afterload relation, but without affecting the peak value
of efficiency. This limitation we presume to arise as a
consequence of insufficient LV diastolic filling due to
diabetes-induced prolongation of twitch duration and
consequent abbreviation of diastole.
Given the above considerations, we hypothesise that
efficiency-afterload relations will be no different between
the tissues isolated from diabetic and control hearts
(Figure 1B). To test this hypothesis, we utilised isolated
left ventricular trabeculae. The use of isolated cardiac
tissues eliminates the intrinsic complexity of the ventricle
and obviates the effect of insufficient diastolic filling.
Methods
Ethical approval
All the procedures of handling and use of animals were
approved by the University of Auckland Animal Ethics
Committee (Approval R925).Figure 1 Qualitative comparison between whole heart data and hypo
efficiency on afterload for the whole heart (STZ-diabetes versus Control). (B
STZ-diabetic heart - the same as that isolated from the Control heart.Animal preparation
Diabetes was induced by a single tail-vein injection of
streptozotocin (STZ, 55 mg kg-1) administered to
male Sprague–Dawley rats (6 weeks - 7 weeks old, 250 g -
300 g). Age- and mass-matched control rats received
intravenous injections of equivalent volumes of saline.
Rats in each group were housed (in pairs) in a cage in a
room (20°C - 22°C) on a 12-hr light/dark cycle. They had
ad lib access to food (standard rat chow) and tap water.
Induction of diabetes in the STZ-treated rats was confir-
med by their elevated levels of blood glucose (>20 mM),
measured daily using a glucometer for a week post-injec-
tion and thence once per week for 7 weeks - 8 weeks.
Preparation of trabeculae
On the day of an experiment (7 weeks - 8 weeks post-
injection), a rat was deeply anaesthetised with isoflurane
(<5% in O2) and, following measurement of its body
mass, injected with heparin (1000 IU kg-1) prior to killing
by cervical dislocation. The excised heart was plunged into
chilled Tyrode solution, and the aorta immediately can-
nulated for Langendorff perfusion with Tyrode solution
(in mM: 130 NaCl, 6 KCl, 1 MgCl2, 0.5 NaH2PO4, 1.5
CaCl2, 10 Hepes, 10 glucose; pH adjusted to 7.4 by
addition of Tris) vigorously gassed with 100% O2 at room
temperature. Once the coronary vasculature was clear of
blood, the heart was mounted on a working-heart rig and
subjected to a series of pressure-volume work-loops at a
range of afterloads, while measuring its rate of oxygen up-
take. At the end of this experiment (which typically lasted
four hours), the details of which can be found in [50], the
heart was removed from the rig and again Langendorff-
perfused with dissection solution (Tyrode solution with
Ca2+ reduced to 0.3 mM and supplemented with 20 mM
2,3-butanedione monoxime). The left ventricle (LV) was
opened and trabeculae (typically located around the papil-
lary muscles) were dissected. A geometrically uniform LV
trabecula was then mounted onto a pair of hooks in ourthesised tissue data. (A) observed dependence of myocardial
) putative efficiency-afterload relation of tissue isolated from the
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0.5 μL s-1 - 0.7 μL s-1) with Tyrode solution. During an
equilibration period (at least one hour), the trabecula,
while electrically stimulated to contract at 3 Hz, was grad-
ually stretched to optimal length (Lo; the length that maxi-
mises developed force). In total, 15 Control trabeculae and
12 STZ trabeculae, obtained respectively from 13 Control
hearts and 11 STZ hearts, were used. The trabeculae did
not differ between groups (Control and STZ) in either
average diameters (227 μm± 17 μm and 195 μm± 17 μm)
or average lengths (2.78 mm± 0.18 mm and 2.58 mm±
0.33 mm).
Experimental protocol
During an experiment, the entire calorimeter system was
enclosed by a light-proof and thermally-insulated lid,
with the temperature within the enclosure maintained
at 32°C. Each experiment commenced with a trabec-
ula contracting isometrically at Lo while paced at 3 Hz
(chosen because this frequency approximates the intrinsic
rate of the isolated rat heart at 32°C [50], and avoids the
increase of diastolic force that accompanies higher rates)
until achieving steady states of force and rate of heat
production. The trabecula was then required to perform a
train of workloop contractions (bracketed by isometric
contractions) at a range of afterloads [51,52], in decreasing
order. Note that the force-length work-loops were de-
signed to mimic the pressure-volume loop of the heart.
This procedure was repeated until the afterload was in the
vicinity of zero developed force. Upon completion of
this ‘work-loop protocol’, the trabecula was required
to undergo an ‘isometric protocol’, during which it
was subjected to isometric contractions at progressively
diminishing muscle lengths, commencing at Lo and pro-
ceeding to the length which produced near zero developed
force. Lastly, the trabecula was required to complete
a ‘length-perturbation protocol’ for measurement of
dynamic stiffness [53].
Measurement of dynamic modulus
In order to interrogate crossbridge status, muscle dy-
namic stiffness was computed, as described previously
[53]. In this protocol, muscle length was sinusoidally
perturbed at 100 Hz at a constant amplitude of 0.001 Lo.
Muscle length perturbation (ΔL) and the resulting
oscillation of twitch force (ΔF) were recorded throughout
the entire time courses of twitches (3 Hz and 6 Hz stimu-
lus frequencies). A sliding window of 7 ms width was ad-
vanced in steps of 1 ms throughout each steady-state
length and twitch force profile. Within this window,
ΔL and ΔF traces were fitted by sinusoidal curves:
ΔX =AX ⋅ sin(2πft) +BX ⋅ cos(2πft) +CX ⋅ t +DX, where X
represents either L or F, f is perturbation frequency









, and mean F as
CF ⋅ tc +DF , where tc is the time at the centre of the
window. Dynamic modulus was calculated as the product
of dynamic stiffness and Lm/Am, where Lm and Am are
muscle length and cross-sectional area, respectively.
Corrections for thermal artefacts
Three thermal artefacts sully the measurement of muscle
heat production. One arises from the slow exponential
drift of temperature with time inside the insulated enclos-
ure when experiments are performed at temperatures
above that of the room. Correction for this behaviour was
effected by subtracting an exponential function fitted to
the heat record obtained with the trabecula in the meas-
urement chamber but in the quiescent state. The contri-
butions from the remaining two sources were determined
at the end of the experiment. During a train of work-loop
contractions, the downstream hook and glass connecting
rod are required to move upstream, repeatedly, to allow
the muscle to shorten. This cyclical movement generates a
heat artefact, thereby requiring correction. The magnitude
of this source, typically <10% of the peak total measured
signal (when the muscle performed isometric contractions
at Lo), was quantified by mimicking the train of workloop
contractions with the stimulator off and the muscle quies-
cent. Stimulus heat was measured in the absence of the
trabecula. The magnitude of the stimulus heat (3 Hz, and
typically 3 V and 3 ms stimulus pulses) was commonly
about 10% of the peak total measured signal.
Definitions and normalisations
Muscle force (N) was converted to stress (kPa) by dividing
by muscle cross-sectional area. Muscle length was ex-
pressed relative to optimal muscle length (L/Lo). A stress-
length workloop has four distinct phases [51]: isometric
contraction, isotonic shortening, isometric relaxation and
isotonic re-lengthening. For a workloop twitch, ‘afterload’
was defined as the user-selected stress at which the
muscle transitioned from the isometric phase to isotonic
shortening. ‘Relative afterload’ (S/So) is the ratio of the
afterload (S) to the peak isometric total (active plus
passive) stress (So). ‘Active afterload’ was defined as the
difference between afterload (S) and passive stress at Lo,
and hence ‘relative active afterload’ was defined as the
ratio of ‘active afterload’ to peak isometric active stress
(at Lo). Muscle ‘shortening’ was defined as the difference
between Lo and the end-systolic length reached during a
workloop contraction (i.e., at the point of transitioning
between isotonic shortening and isometric relaxation) and
was expressed as a percentage of Lo. Maximum velocity of
muscle shortening for each workloop (Vs) was computed
from the length-time trace during the isotonic shortening
Table 1 General characteristics of control and STZ rats
Parameter Control (n=13) STZ (n=11)
Body mass (g) 506 ± 16 363 ± 15*
Tibial length (mm) 44.6 ± 0.6 41.9 ± 0.8*
Blood Glucose (mM) 6.9 ± 0.1 30.0 ± 0.6*
Heart wet mass (g) 1.42 ± 0.05 1.13 ± 0.04*
Heart dry mass (g) 0.27 ± 0.01 0.22 ± 0.01*
Heart wet mass/body mass (%) 0.28 ± 0.01 0.31 ± 0.01*
RV wall thickness (mm) 1.29 ± 0.05 1.18 ± 0.08
RV thickness/heart wet mass (mm g-1) 0.92 ± 0.04 1.07 ± 0.09
Septal wall thickness (mm) 3.17 ± 0.10 3.02 ± 0.13
Septal thickness/heart wet mass (mm g-1) 2.25 ± 0.07 2.72 ± 0.17*
LV wall thickness (mm) 3.82 ± 0.07 3.65 ± 0.12
LV thickness/heart wet mass (mm g-1) 2.72 ± 0.11 3.26 ± 0.12*
Values are means ± SE. *P < 0.05.
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thus expressed in units of s-1. Power of shortening (Ps) is
the product of Vs and ‘active afterload’. External mechan-
ical work is the area of the workloop (calculated by inte-
grating stress as a function of L/Lo over the entire period
of the twitch) and was expressed in units of kJ m-3.
Change of enthalpy (kJ m-3) is the sum of work and heat.
Mechanical efficiency is the ratio of work to change of
enthalpy and was thus expressed as a percentage. For
calculation of crossbridge efficiency, the denominator of
the foregoing ratio was reduced by subtraction of the heat
of activation of work-loop contractions (extrapolated as
the intercept of the heat-S/So relation). The duration of
the twitch (expressed in ms) was quantified at 5% and 50%
of the peak stress [54]. For an isometric twitch, the area
under the twitch profile is defined as the stress-time
integral (STI) and has units of kPa s. The maximum rates
of rise and fall (±dS/dt; MPa s-1) of twitch stress were
computed from the ascending and descending limbs of
the twitch, respectively.
Curve fitting
For the data obtained from the ‘isometric protocol’, total
stress and passive stress were plotted against L/Lo and
fitted using 3rd-order polynomials. Twitch duration, and
±dS/dt, were plotted against active stress and fitted using
1st-order polynomials. STI was plotted against active
stress and fitted using 2nd-order polynomials. Heat was
plotted against both active stress and STI. These
relations were fitted using 2nd-order and 1st-order
polynomials, respectively. For the ‘work-loop protocol’,
shortening was plotted against ‘relative active afterload’
and fitted using a 2nd-order polynomial. Velocity of short-
ening (VS ) was plotted against relative active afterload
(SA/So) and fitted using the Hill hyperbolic velocity-load
function: VS = b(c − SA/So)/(a − SA/So), where a, b and c
were obtained through least-squares optimisation. Note
that we did not constrain VS to pass through SA/So = 1,
given that VS − SA/So data are poorly described by the Hill
function when SA/So > 0.8 [55]. The relation between
shortening power (PS) and SA/So was derived from
the VS − SA/So relation. Heat and change of enthalpy
were plotted against relative afterload S/So and fitted
using 1st-order and 2nd-order polynomials, respectively.
Work and both mechanical and crossbridge efficiencies
were plotted against S/So and fitted using 3
rd-order poly-
nomials constrained to pass through (0, 0) and (0, 1).
Statistical analyses
The regression lines (each obtained from a single trabecula)
were averaged within groups using either the ‘random coef-
ficient’ model within Proc Mixed for 1st-order and 2nd-order
polynomials, or Proc Nlmixed for 3rd-order polynomials, of
the SAS software package (SAS Institute Inc., Cary, USA).The ‘random coefficient’ model treats the regression
coefficients arising from measurements made in individual
trabeculae as a random sample from a multivariate normal
population of possible coefficients [56].
Parameters of interest (peak values of shortening,
shortening velocity, shortening power, work and effi-
ciency), estimated from the appropriate regression lines,
were averaged and compared between the Control and
STZ groups. The data arising from isometric contrac-
tions (i.e., peak values of twitch stress, twitch duration
and twitch heat) were averaged and compared between
the Control and STZ groups. Analysis of variance was
performed for each of these variables, using the ‘general-
ised linear model’ of SAS, accounting for both the vari-
ability among trabeculae from different hearts and that
between trabeculae within individual hearts. All values
were expressed as mean ± standard error (SE). Statistical
significance was declared when p < 0.05.
Results
Morphometric characteristics of the rats
Morphometric characteristics of the subset of hearts
from rats [50] that yielded trabeculae of suitable dimen-
sions are presented in Table 1. A single injection of strep-
tozotocin (STZ) resulted in hyperglycaemia. Compared
with the Control rats, the STZ-diabetic rats were smaller,
as indicated by their lower average body masses and aver-
age shorter tibial lengths. STZ-treatment also resulted in
LV hypertrophy, as evident by the increased average septal
and LV wall thicknesses (relative to heart wet mass) of the
STZ rats.
Isometric contractions
Each trabecula (n = 15 Control and n = 12 STZ) was
subjected to isometric contractions in decreasing order
of muscle length (i.e., ‘isometric protocol’). Twitch stress
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(L/Lo) and quadratic regression lines used to fit separ-
ately to the total stress and passive stress (Figure 2A).
The relations of the total stress-length and passive
stress-length for all the trabeculae in each group were
averaged (Figure 2C). Diabetes had no effect on these
relations. The average peak stresses (total stress, active
stress and passive stress), obtained at L = Lo, did not
differ between the Control (84.7 kPa ± 7.7 kPa, 66.3
kPa ± 6.9 kPa and 18.3 kPa ± 1.8 kPa) and the STZ
trabeculae (81.1 kPa ± 8.0 kPa, 64.7 kPa ± 6.7 kPa and
16.4 kPa ± 2.8 kPa). The measured rate of heat production
(Figure 2B) was converted to heat per twitch by dividing
by stimulus frequency (3 Hz). Peak twitch heat did not
differ between groups (11.2 kJ m-3 ± 1.0 kJ m-3 for Control
and 11.0 kJ m-3 ± 1.0 kJ m-3 for STZ).
Isometric twitch duration
The duration of isometric twitch stress was quantified at
5% and 50% of peak stress, and was partitioned into
contraction and relaxation phases. These were plotted
against active stress (Figure 3). Diabetes prolonged the
time courses of both contraction (Figure 3A and B) and
relaxation (Figure 3C and D), i.e., the average duration-
stress regression lines of the STZ trabeculae were higher
than those of the Control trabeculae. The average peak
values (obtained when L = Lo) of twitch duration (con-
traction, relaxation and total) at 5% of peak stress wereFigure 2 Isometric stress-length relations and original record of rate
stress-length relation of a representative trabecula. The upper and lower br
respectively. The inset shows the individual twitch stress profiles (in order of d
a representative trabecula undergoing isometric contractions at progressively
passive (lower lines) stress-length relations for the n = 15 Control (thin lines) agreater for the STZ trabeculae (79.2 ms ± 1.5 ms, 144.2
ms ± 2.9 ms and 223.5 ms ± 2.1 ms) than for the Con-
trol trabeculae (68.5 ms ± 1.8 ms, 120.3 ms ± 3.4 ms
and 188.8 ms ± 4.5 ms). Similar results obtained at 50%
of peak stress (STZ: 53.1 ms ± 1.2 ms, 73.8 ms ± 1.3 ms
and 126.9 ms ± 1.7 ms; Control: 45.5 ms ± 1.3 ms, 60.3
ms ± 2.0 ms and 105.7 ms ± 3.0 ms).
Rates of rise and fall of isometric twitch stress and
stress-time integral
The maximal rates of rise (+dS/dt) and fall (−dS/dt) of iso-
metric twitch stress were expressed as functions of active
stress. The average relations describing dS/dt and active
stress (Figure 4B) of the STZ groups were positioned lower
than those of the Control groups, implying that diabetes
slows the kinetics of isometric twitch stress. On the other
hand, the average relation between stress-time integral
(STI) and active stress (Figure 4D) was greater for the STZ
trabeculae than for the Control trabeculae. This result
reflects the fact that, at any given active stress, the STZ tra-
beculae have a greater value of STI due to their prolonged
twitch duration (Figure 3), and their stress values were
statistically not different to the Control values (Figure 2C).
Isometric heat as functions of stress and stress-time
integral
Rate of heat production (Figure 2B) was converted to
heat per twitch by dividing by stimulus frequency (3 Hz).of heat production at 3 Hz stimulation. (A) Steady-state isometric
oken lines represent the fitted total and passive stress-length relations,
ecreasing muscle length, a to g). (B) Record of rate of heat production of
diminishing muscle lengths (a to g). (C) Average total (upper lines) and
nd n = 12 STZ (thick lines) trabeculae.
Figure 3 Isometric twitch durations as functions of active stress at 3 Hz stimulation. Time courses of the contraction phase (A and B) and
relaxation phase (C and D) and their sum (E and F) of the isometric twitch, quantified at 5% (t5) and 50% (t50) of peak stress. Data from a
representative trabecula from the Control group (open symbols) and from the STZ group (filled symbols) (left panels) and the average relations
for n = 15 Control (thin lines) and n = 12 STZ (thick lines) trabeculae (right panels).
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functions of steady-state values of active stress (Figure 5A
and B). Diabetes had no effect on the average heat-stress
relation, or on the average heat at zero active stress
(Control: 2.52 kJ m-3 ± 0.39 kJ m-3; STZ: 3.15 kJ m-3 ±
0.43 kJ m-3). Twitch heat was also plotted as a function of
stress-time integral, STI (Figure 5C and D). Diabetes had
no effect on the heat at zero active stress (Control:
2.63 kJ m-3 ± 0.38 kJ m-3; STZ: 3.24 kJ m-3 ± 0.42 kJ m-3),
but lowered the slope (Control: 1.24 s ± 0.05 s; STZ:
0.98 s ± 0.05 s) of the average heat-STI relation. This is
consistent with the diabetes-induced prolongation of
twitch duration (Figure 3).
Dynamic modulus
Given the prolonged twitch duration (Figure 3), slowed
kinetics and increased STI (Figure 4) of the diabetic
trabeculae, we interrogated crossbridge status during the
time-course of twitch stress production by measuring
dynamic modulus. Dynamic modulus (dynamic stiffnessnormalised to muscle cross-sectional area and length)
was calculated from the amplitudes of the sinusoidally-
perturbed twitch stress (Figure 6A) and sinusoidally-
perturbed muscle length (0.001 Lo), and plotted against
both the time-course (Figure 6B) and the amplitude
(Figure 6C) of mean twitch stress. The maximal and
minimal values of dynamic modulus, which occur respect-
ively at the peak active stress and diastolic stress, were not
different between the Control and the STZ trabeculae
(Figure 6D and E). Likewise, the slopes of the modulus-
stress relations (Figure 6C), calculated by linear regression
analyses, were also not different between groups, at either
3 Hz or 6 Hz stimulus frequency.
Twitch stress at 6 Hz stimulation
We reduced the diastolic period during a contraction by
challenging the trabeculae to contract at a high stimulus
frequency (6 Hz). At 6 Hz stimulation (and at Lo),
trabeculae experienced incomplete relaxation of stress
between consecutive twitches, as shown by the double-
Figure 4 Rates of rise and fall of isometric twitch stress, and stress-time integral, as functions of active stress, at 3 Hz stimulation.
Maximal rate of rise (upper lines) and rate of fall (lower lines) (A), and stress-time integral (STI) (C), as functions of active stress for a representative
trabecula from the Control group (open symbols) and from the STZ group (filled symbols). Average relations (B and D) for the Control (thin lines)
and the STZ (thick lines) trabeculae. The slopes of the relations shown in B and in D are significantly different between the Control and the
STZ groups.
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expressing its value as a fraction of the value of active
stress at 3 Hz. As shown in Figure 7A, the average relative
diastolic stress at 6 Hz was greater in the STZ trabeculae,
indicating that the STZ trabeculae were unable to relax
between twitches to the same degree as the ControlFigure 5 Twitch heat as functions of active stress and stress-time inte
(B and D) heat-stress and heat-STI (stress-time integral) relations under iso
and STZ (thick lines) trabeculae. The slope of the average heat-STI relationtrabeculae. Their average active stress at 6 Hz (as a frac-
tion of that at 3 Hz) was lower than that of the Control
trabeculae (Figure 7B). These results are consistent with
the significantly prolonged twitch duration of the STZ
trabeculae at 6 Hz. At 5% of peak active stress, their
average contraction duration was 57.0 ms ± 1.2 ms (versusgral at 3 Hz stimulation. Representative (A and C) and average
metric contractions at variable muscle lengths for Control (thin lines)
(in D) is lower in the STZ group.
Figure 6 Dynamic modulus at 3 Hz and at 6 Hz stimulations. (A) Representative muscle length-perturbed twitch stresses at 3 Hz (thin trace)
and 6 Hz (thick trace) stimulus frequencies. The arrow indicates the extent of increase of diastolic stress at 6 Hz. Representative calculated dynamic
modulus throughout the time-course of a twitch (B) and as a function of mean active stress (C). No significant difference in the average maximal
(D) and average minimal (E) dynamic modulus, and the average slope of the modulus-stress relation (calculated by linear regression of the data
in C) (F), between the Control (open bars) and the STZ (filled bars) trabeculae.
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duration was 88.5 ms ± 1.1 ms (versus 84.2 ms ± 1.3 ms),
and their average total duration was 145.5 ms ± 0.5 ms
(versus 136.6 ms ± 1.9 ms). Likewise, at 50% of peak active
stress, their average durations for contraction, relaxation,
and total were, respectively, 37.7 ms ± 0.6 ms (versus 34.3Figure 7 Peak isometric twitch stress at 6 Hz stimulation. Diastolic stre
stress at 3 Hz. *P < 0.05.ms ± 0.9 ms), 47.0 ms ± 0.7 ms (versus 42.6 ms ± 1.4 ms),
and 84.7 ms ± 0.8 ms (versus 77.0 ms ± 2.1 ms).
Work-loop contractions
Each trabecula was also subjected to work-loop con-
tractions (at 3 Hz stimulus frequency) in the order ofss (A), and active stress (B), both expressed as fractions of the active
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traction was interleaved with an isometric contraction.
Figure 8A shows superimposed steady-state twitch stress
for an isometric contraction (a) and for work-loop con-
tractions (b - h). The associated change of muscle length
is plotted in Figure 8B. Twitch stress is also plotted against
muscle length (Figure 8C), and the resulting area of a
work-loop stress-length relation quantifies the external
work output of the trabecula. Rate of heat production
accompanying the isometric and work-loop contractions
during the entire period of experiment is depicted in
Figure 8D.
Duration of work-loop twitches
The durations of the work-loop twitch profiles were
quantified at 5% and 50% of peak stress, and plotted
against afterload (relative to the isometric total stress),
as shown in Figure 9. Diabetes prolonged the durations
(5% and 50%) of work-loop twitches at all relative after-
loads (Figure 9B).
Extent of shortening, shortening velocity and shortening
power
The extent of muscle shortening during work-loop con-
tractions was calculated from the end-systolic lengthFigure 8 Twitch stress, length change and rate of heat production of
contraction (a) superimposed with work-loop twitch stress profiles at vario
length changes throughout the time-courses of twitch stresses in A. The grey
were maximal. (C) Parametric plots of the data in A against those in B. (D) Rec
contractions (b – h), bracketed by 8 isometric contractions (a).(at which point the muscle transitions from the isotonic
shortening phase to the isometric relaxation phase of the
work-loop; Figure 8A-C), and expressed as a percentage of
Lo. Diabetes had no effect on the average peak extent of
shortening (extrapolated to zero relative active afterload);
Control: 10.2% ± 0.5%, STZ: 11.0% ± 0.8% (Figure 10B).
Shortening velocity was calculated as the maximal slope
of the length-time trace (Figure 8B, grey circles) and
normalised to Lo. Diabetes had no effect on the average
peak shortening velocity; Control: 2.27 s-1 ± 0.15 s-1; STZ:
2.72 s-1 ± 0.27 s-1 (Figure 10D). Shortening power was
computed as the product of shortening velocity and active
afterload. Once again, diabetes had no effect on this index
of mechanics, Control: 35.6 kW m-3 ± 5.2 kW m-3; STZ:
32.4 kW m-3 ± 3.8 kW m-3 (Figure 10F), quantified at a
relative active afterload of 0.6 (i.e., in the vicinity of peak
shortening power).
Heat, change of enthalpy, work and efficiency
We plot the heat production, external work output,
change of enthalpy (work plus heat), mechanical efficiency
(the ratio of work to change of enthalpy) and crossbridge
efficiency as functions of relative afterload in Figure 11.
Crossbridge efficiency was revealed by subtracting,
from the denominator of the expression for mechanicalisotonic work-loops. (A) Steady-state twitch stress of an isometric
us afterloads (b – h) of a representative trabecula. (B) Corresponding
circles indicate the locations at which velocities of muscle shortening
ord of rate of heat production for 7 variously-afterloaded work-loop
Figure 9 Duration of work-loop twitches as functions of relative afterload. (A) Total duration of work-loop twitch stress, quantified at 5%
(upper lines) and 50% (lower lines) of afterload, for a representative trabecula from the Control group (open symbols) and from the STZ group
(filled symbols). (B) Average relations for the Control (thin lines) and STZ (thick lines) trabeculae. No difference between average slopes of
regression lines at either t5 of t5o but their elevations higher in the STZ group.
Figure 10 Extent of shortening, shortening velocity and shortening power as functions of relative active afterload. (A and B) Maximal
extent of shortening (calculated from the end-systolic length in Figure 7C), (C and D) maximal velocity of shortening (at the times indicated by
the circles in Figure 7B), and (E and F) maximal power of shortening (calculated as the product of velocity of shortening and active afterload) as
functions of relative active afterload for a representative trabecula (left panels) and the average relations (right panels) for the Control (thin lines)
and STZ (thick lines) trabeculae.
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Figure 11 Energy expenditure, work output and efficiency as functions of relative afterload. (A) Change of enthalpy (squares) and
heat (circles), (C) work output, (E) mechanical efficiency and (G) crossbridge (‘XB’) efficiency as functions of relative afterload for a representative
trabecula. The corresponding average relations for the Control (thin lines) and STZ (thick lines) trabeculae are shown in B, D, F and H, respectively.
The left and the right vertical dotted lines indicate, respectively, the relative afterloads for peak mechanical efficiency and for peak work.
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extrapolated using the linear heat-afterload relation
(Figure 11A and B). The average extrapolated heat
values did not differ between the Control and the STZ
trabeculae (4.87 kJ m-3 ± 0.62 kJ m-3 versus 4.63 kJ m-3 ±
0.69 kJ m-3).
We interpolated the values of the above variables at
two values of relative afterload: one when mechanical
efficiency was at its peak (0.44 S/So - 0.47 S/So) and the
other when work was at its peak (0.53 S/So - 0.56 S/So).
Peak work (1.78 kJ m-3 ± 0.29 kJ m-3 versus 1.61 kJ m-3 ±
0.20 kJ m-3) and peak mechanical efficiency (17.5% ± 1.0%
versus 17.4% ± 1.3%) did not differ between the Control
and the STZ trabeculae. At the relative afterload that
gave peak mechanical efficiency, the heat (8.11 kJ m-3 ±
0.95 kJ m-3 versus 7.84 kJ m-3 ± 0.84 kJ m-3), change ofenthalpy (9.86 kJ m-3 ± 1.23 kJ m-3 versus 9.34 kJ m-3 ±
0.99 kJ m-3), work (1.71 kJ m-3 ± 0.28 kJ m-3 versus
1.55 kJ m-3 ± 0.19 kJ m-3), and crossbridge efficiency
(34.6% ± 1.3% versus 33.8% ± 1.5%) were not different
between Control and STZ trabeculae. Likewise, at the
relative afterload at which work peaked, the heat
(8.82 kJ m-3 ± 1.03 kJ m-3 versus 8.52 kJ m-3 ± 0.93 kJ m-3),
change of enthalpy (10.64 kJ m-3 ± 1.34 kJ m-3 versus
10.06 kJ m-3 ± 1.11 kJ m-3), mechanical efficiency (16.8% ±
0.9% versus 16.7% ± 1.1%) and crossbridge efficiency
(31.3% ± 1.3% versus 30.9% ± 1.5%) were not differ-
ent between groups.
Discussion
In this study, we present the first results of STZ-induced
diabetes on the energetics of isolated left-ventricular
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twitch duration. We measured mechanical work output
and heat production. Several additional first results from
diabetic cardiac preparations are also presented: (1)
twitch duration as a function of stress or afterload, (2)
heat-stress and heat-STI (stress-time integral) relations
obtained under isometric contractions, (3) dynamic modu-
lus as a function of isometric twitch stress, and (4) heat-
afterload, work-afterload and efficiency-afterload relations
derived from work-loop contractions. Given these results,
we are in a position to reconcile the performance of the
isolated cardiac muscle with that of the intact heart.
Relation of trabecula performance to that of the whole heart
Diabetes prolongs twitch duration in both isolated tra-
beculae and the heart, but contractile dysfunction
prevails only in the heart. In our recent study of isolated,
working, hearts [50], we showed that the maximal after-
load achievable by the diabetic heart (i.e., when its aortic
outflow is near zero) is substantially lower than that of
Control hearts. Thus, at high afterloads, the work output
of the diabetic heart is compromised. In contrast, dia-
betes does not affect the stress development of isolated
trabeculae (Figure 2C) nor any other index of mechano-
energetic performance, with the single exception of twitch
duration, which is prolonged in diabetic preparations
under both isometric (Figure 3) and work-loop (Figure 9)
protocols. Because of the comparability of mechanical
performance, the efficiency-afterload curve of the diabetic
trabeculae is the same as that of the Control group
(Figure 11F). Note that the null effect of diabetes on the
absolute stress production of trabeculae allows us to
express efficiency as a function of relative afterload.
When a trabecula is isolated from a diabetic heart, it is
freed from the effects of insufficient ventricular filling. It
can now be stretched to Lo, where its stress development
is found to be as high as that of healthy Control trabe-
culae (Figure 2C). This finding gives us confidence that
sub-optimal ventricular filling, as a consequence of
prolonged twitch duration and attendant abbreviation of
diastolic interval, is sufficient to explain LV contractile
dysfunction in the heart. Hence, twitch prolongation
alone is sufficient to develop LV contractile dysfunction
at high afterloads. That is, prolonged twitch duration
reduces the period, and hence the extent, of diastolic
refilling, leading to failure to generate the high pressures
required to overcome high afterloads. This, however,
does not compromise peak stress development at the
level of isolated myocardial tissue. Consequently, diabetes
does not affect the efficiency-afterload relation of isolated
trabeculae, as hypothesised.
To explain further the apparent contradiction between
the contractile performance of the heart and isolated
trabeculae, it is necessary to consider four facts: (1)twitch duration increases with increasing muscle length
(Figure 3), as well as with afterload (Figure 9), (2) for a
given pacing rate, prolongation of twitch duration is asso-
ciated with a reduction of the diastolic period (Figure 2A
inset and Figure 8A), i.e., reducing the time for diastolic
filling of the ventricles or re-lengthening of isolated tra-
beculae, (3) the extent of reduction of the diastolic period
increases with increasing stimulus frequency (Figure 6A)
or heart rate, and (4) the reduced intrinsic heart rate of
the diabetic animal [6,32,40,42,44,50].
Consideration of these facts requires comparison of
twitch duration between the diabetic heart and the Con-
trol heart at the same rate of stimulation. This can be
achieved by externally pacing the heart. In our heart
study, we paced the hearts to beat at 4 Hz, which is
above their intrinsic rate at 32°C: 2.6 Hz and 2.9 Hz for
the STZ and Control groups, respectively [50]. We did
not measure twitch duration of the heart and are
unaware of any study that has paced the diabetic heart
at the same rate as the Control heart in order to quantify
the diabetes-induced prolongation of twitch duration.
However, we can make use of the trabecula results of
the current study in order to draw an inference concern-
ing the contractile dysfunction of the diabetic heart at
high afterloads. We electrically stimulated diabetic tra-
beculae to contract at the same rate as their controls
(3 Hz). By doing so, we saw a diabetes-induced pro-
longation of twitch duration (Figure 3), consistent with
the results of others in isolated papillary muscles
[2,3,28,30,34-37], ventricular trabeculae [6,12], and single
myocytes [13,31,38,39]. We infer that the same behav-
iour occurs in the diabetic heart.
Collectively, our results allow us to infer that the
diastolic filling time of the diabetic heart is reduced, and
is disproportionately reduced as the afterload challenge
is increased. Hence, at sufficiently high afterloads, the
diabetic heart suffers inadequate ventricular filling and,
consequently, reduced aortic outflow. The healthy heart,
in contrast, can pump to a higher afterload given its
longer period of diastolic filling.
Frequency-dependence of peak active stress
The null effect of diabetes on peak active stress of
isolated trabeculae renders our hypothesis valid. Many
previous studies have also reported a null effect of
diabetes on peak active stress (i.e., when the muscle is
held at Lo) at stimulus frequencies ≤ 1 Hz in isolated
papillary muscles [2,3,28,30,34-37] and in isolated single
myocytes [46,47,49]. But, there are several studies show-
ing lower contractility of diabetic myocytes at stimulus
frequencies ≤ 1 Hz [31,38,57] as well as at 2 Hz [29]. The
reason for these discrepant literature findings is unclear
given that these experiments were performed at compar-
able temperatures (30°C – 37°C). Given these ambiguous
Han et al. Cardiovascular Diabetology 2014, 13:79 Page 13 of 16
http://www.cardiab.com/content/13/1/79literature reports, we compared the results of four inde-
pendent studies which examined the effect of stimulus
frequency at a fixed temperature: Cameron et al. [34]
and Nobe et al. [3] on isolated papillary muscles, Zhang
et al. [6] on isolated LV trabeculae, and Ren and David-
off [39] on isolated single myocytes. The first study
showed no effect of diabetes on peak active stress at 30°C
and at a range of stimulus frequency between 0.1 Hz and
4 Hz. The second reported no effect of diabetes on peak
active stress at 36°C between 0.2 Hz and 5 Hz. The third
study, at 37°C, showed no effect of diabetes at 1 Hz or
2.5 Hz, but lower values at 5 Hz and 7 Hz. Lastly, the
fourth study, also at 37°C, found the differential effect of
diabetes to disappear at 5 Hz, but not at frequencies below
2 Hz. We have no explanation for the discrepant findings
between the latter studies. We conclude that the effect of
diabetes on peak active stress production appears to be
dependent on stimulus frequency. Our results, at 32°C,
show no effect of diabetes on the peak active stress
production at 3 Hz stimulation, but a negative effect at
6 Hz (Figure 7B).
Frequency-dependence of diastolic stress
At 6 Hz, relaxation of the twitch is incomplete in both
Control and diabetic trabeculae (Figure 6A), resulting in
the elevation of diastolic stress between successive
twitches. We have previously shown [53] that, in healthy
trabeculae, incomplete relaxation is initiated by elevation
of diastolic intracellular Ca2+ and a subsequent decreased
myofilament sensitivity to Ca2+, and is not due to inad-
equate supply of either glucose or oxygen. Compared with
the Control trabeculae, the diabetic trabeculae experience
greater diastolic stress (Figure 7A), indicating that they fail
to relax between twitches as fully as that of the Control.
The inability of the diabetic trabeculae to achieve com-
plete relaxation at 6 Hz is exacerbated by their prolonged
twitch duration. The diabetic trabeculae have less time to
relax before the next twitch commences, and conse-
quently, they experience a greater extent of incomplete
twitch relaxation. This result implies that the diastolic
intracellular Ca2+ at 6 Hz is greater in the diabetic
trabeculae, and the decrease of sensitivity of myofilaments
to Ca2+ is more severe in the diabetic trabeculae. The
latter implication is consistent with the findings of Zhang
et al. [12] and Op Den Buijs et al. [58] showing a diabetes-
induced decrease of Ca2+ responsiveness.
Dynamic stiffness as a probe of cross-bridge function
Because of the well-documented negative effect of
diabetes on actomyosin ATPase activity (see above), we
invoked the technique of high-frequency, low-amplitude
oscillation of muscle length in order to interrogate
crossbridge function. We measured dynamic modulus
(dynamic stiffness normalised to muscle dimensions) toquantify the status of crossbridges (i.e., the number
attached and their individual stiffness) throughout the
time course of twitch stress production.
We find no effect of diabetes on dynamic modulus
(Figure 6). The linear relation between dynamic modulus
and active stress (which implies that the net number of
attached crossbridges changes linearly with stress produc-
tion) is unaffected by diabetes. The maximal and minimal
values of dynamic modulus, obtained at the peak stress
and diastolic stress, respectively, are also unaffected by
diabetes. Our modulus result, at high perturbation fre-
quency (100 Hz), is consistent with that of Metzger et al.
[59], who demonstrated that the modulus-tension rela-
tions are similar between control and β-MHC-expressing
ventricular myocytes of the hypothyroid rat. These
authors inferred that “… force production per strong
crossbridge interaction, or the distribution of force-
generating crossbridge states, is not cardiac MHC isoform
dependent”. Thus, our results suggest that, although
diabetes prolongs twitch duration, it does not affect the
net number of crossbridges attached or their individual
stiffness. This inference further suggests that the contract-
ile dysfunction at the whole heart level is predominantly
due to insufficient LV diastolic filling, and not to cross-
bridges status per se.
Heat production
During a train of isometric contractions, trabeculae per-
form negligible external work, and hence the metabolic
change of enthalpy (heat plus work) consists almost
entirely of heat. We plotted isometric heat as functions
of both developed stress and STI (Figure 5). Both relations
have previously been used for studying the mechano-
energetic of healthy, non-diabetic, isolated papillary
muscles [60,61] and trabeculae [53,62] under a variety
of experimental conditions. In the present study, we ob-
served the heat-stress relation to be slightly curvilinear
but the heat-STI relation to be linear. The extrapolated
y-intercepts of these relations, which did not differ
and were unaffected by diabetes, are presumed to es-
timate ‘activation heat’, i.e., the energy expenditure asso-
ciated with Ca2+ cycling by the sarcoplasmic reticulum
Ca2+-ATPase and Na+ extrusion by the sarcolemmal
Na+-K+ ATPase. Note that the null effect of diabetes on
activation heat obtained in this study is not at odds with
reports showing decreased activities of both the sarcoplas-
mic reticular Ca2+-ATPase [17-22] and the sarcolemmal
Na+-K+-ATPase [14-16] in diabetic cardiac preparations.
This is because a decreased activity of an ATPase does not
imply decreased metabolic energy expenditure, since the
same total amount of heat could be produced independ-
ent of the rate of ATP hydrolysis.
Under the assumption that the activation heat is
independent of developed stress, the monotonic increase
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bolic energy expenditure of the contractile apparatus by
the actin-activated myosin-ATPase. The inverse of the
slope of the heat-stress relation (Figure 5B) is hence an
index of crossbridge economy. The absence of a differ-
ence in the magnitudes of this index between the healthy
and STZ-treated trabeculae implies that diabetes does
not render the contractile apparatus less ‘economic’,
despite reports showing reduced rate of ATP hydrolysis
by myofibrillar-ATPases [23-28]. Since twitch duration is
prolonged but twitch stress is unaffected, the area under
the time-course of the twitch (i.e., its stress-time
integral, STI) is increased in the diabetic preparations
(Figure 4D). For a given value of active stress, heat
production is unchanged in the diabetic preparations
(Figure 5B). Given the effects of diabetes on twitch
duration, twitch stress and twitch heat, the slope of the
heat-STI relation is destined to be lower in the intact
diabetic trabeculae, as confirmed in Figure 5D.
Our results, showing the effect of diabetes on the
heat-stress relation of intact LV trabeculae at 32°C, are
not comparable with those of Rundell et al. [63] who
used skinned RV trabeculae at 20°C. Those authors
reported decreased tension cost (indexed by the slope of
the linear ATPase-tension relation) in the diabetic group,
which they attributed to reduced expression of the α-
MHC (fast) isoform. Studies by Holubarsch et al. [64,65],
using intact LV papillary muscles at 21°C, showed that
hypothyroid rats (expressing β-MHC) have a lower slope
of the heat-STI relation, in agreement with our result
(Figure 5D). Thus, the use of intact versus skinned
preparations may be responsible for the inconsistency of
our heat-stress relation with that of the ATPase-tension
relation of Rundell et al. [63].
Null effect of diabetes on muscle shortening
The heart does not ever perform purely isovolumic
contractions. Rather, it reduces volume in the process of
ejecting blood. During the ejection period, when the
outflow valves are open, pressure and volume change
continuously. We approximated the pressure-volume
loops of the heart by subjecting each trabecula to a
series of isotonic stress-length loops (Figure 8). Using
the data obtained during the isotonic shortening phases
of the stress-length loops, we quantified three parameters
related to muscle shortening: (i) the peak velocity of short-
ening, computed as the maximal slope of the length-time
trace during the isotonic shortening phase of the work-
loop (Figure 8B), (ii) the power of shortening, which is the
product of maximal velocity of shortening and active
afterload, and (iii) the peak extent of shortening, cal-
culated as the relative length at which the trabecula
transitioned from isotonic shortening to isometric relax-
ation (Figure 8B and C). The latter (end-systolic) lengthcorresponds to the end-systolic volume of the heart. We
found that the peak extent of shortening, as well as its
peak velocity (extrapolated to the y-intercept), was
comparable between control and diabetic trabeculae
(Figure 10B and D). Shortening power also did not
differ between the two groups (Figure 10F). These results
imply that shortening is unaffected by diabetes, and are
thus in accord with the findings of many [13,46-49] but
not all [31,38,57] single-myocyte studies.
Our finding of an absence of effect of diabetes on
shortening velocity is not consistent with those studies
showing a shift of myosin heavy-chain expression from
the α to the β isoform [20,24,26,29,30]. We note that the
velocity of shortening of diabetic preparations is depen-
dent on extracellular Ca2+ concentration. Fein et al. [36]
found that muscle shortening, both its velocity and
its extent, were similar between control and diabetic
rat papillary muscles at a bath Ca2+ concentration of
0.6 mM. But at an elevated (and non-physiological)
Ca2+ concentration (2.4 mM), the shortening velocities of
the diabetic preparations were lower than those of the
control group. Similarly, Siri et al. [66] showed the peak
extent of shortening to be unchanged, but shortening
velocity reduced, in diabetic-hypertensive rat papillary
muscles tested with 2.4 mM Ca2+. Joseph et al. [67] also
reported decreased peak shortening velocity in the dia-
betic papillary muscle at 2.5 mM Ca2+. Whether the
activity of the MHC is Ca2+-dependent requires future
experiments. Our results, at physiological Ca2+ (1.5 mM),
show no effect of diabetes on muscle shortening.
Crossbridge efficiency
Lastly, crossbridge efficiency, revealed by subtracting
activation heat (extrapolated from the heat-relative after-
load relation shown in Figure 11B) from the denomin-
ator of the expression for mechanical efficiency, is also
indifferent to diabetic status (Figure 11H). The null
effect of diabetes on crossbridge efficiency is consist-
ent with that reported by Joseph et al. [67]. These
authors calculated, using their experimental force and
velocity data, together with several assumptions about
crossbridge characteristics and energetics, a value of
crossbridge efficiency of 30%, in agreement with our
experimentally measured values (Figure 11H).
Conclusions
Our collective results from isolated LV trabeculae allow
us to infer that diabetes-induced prolongation of the
twitch reduces the period, and hence the extent, of left-
ventricular diastolic filling. In consequence, the diabetic
heart is incapable of pumping at afterloads exceeding
about two-thirds of the maximum achievable by the
healthy heart [50], resulting in a left-shift of its efficiency-
afterload curve. However, in isolated trabeculae, which are
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the efficiency-afterload curve is unaffected by diabetes.
We conclude that the peak efficiency of the heart and its
tissues is unaffected by diabetes.
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